Read + Share
Amedeo Smart
Independent Medical Education
Brand-Wiita S, Tsai CJ, Liu YH, Beaulieu E, et al. Cost-effectiveness of pembrolizumab as a treatment for FIGO 2014 stage III-IVA cervical cancer in the United States. Gynecol Oncol 2026;210:1-9.PMID: 42150374
Email
LinkedIn
Privacy Policy